Newron Pharmaceuticals (Switzerland) Probability of Future Stock Price Finishing Under 7.2
| NWRN Stock | CHF 7.20 0.08 1.10% |
Newron |
Newron Pharmaceuticals Target Price Odds to finish below 7.2
The tendency of Newron Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move below current price in 90 days |
| 7.20 | 90 days | 7.20 | about 6.62 |
Based on a normal probability distribution, the odds of Newron Pharmaceuticals to move below current price in 90 days from now is about 6.62 (This Newron Pharmaceuticals SpA probability density function shows the probability of Newron Stock to fall within a particular range of prices over 90 days) .
Assuming the 90 days trading horizon Newron Pharmaceuticals has a beta of 0.17. This indicates as returns on the market go up, Newron Pharmaceuticals average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Newron Pharmaceuticals SpA will be expected to be much smaller as well. Additionally Newron Pharmaceuticals SpA has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Newron Pharmaceuticals Price Density |
| Price |
Predictive Modules for Newron Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Newron Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Newron Pharmaceuticals Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Newron Pharmaceuticals is not an exception. The market had few large corrections towards the Newron Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Newron Pharmaceuticals SpA, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Newron Pharmaceuticals within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.1 | |
β | Beta against Dow Jones | 0.17 | |
σ | Overall volatility | 0.48 | |
Ir | Information ratio | -0.06 |
Newron Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Newron Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Newron Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Newron Pharmaceuticals generated a negative expected return over the last 90 days | |
| Newron Pharmaceuticals has high historical volatility and very poor performance | |
| Newron Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 5.76 M. Net Loss for the year was (14.9 M) with profit before overhead, payroll, taxes, and interest of 5.76 M. | |
| Newron Pharmaceuticals SpA has accumulated about 58.99 M in cash with (11.45 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.31. |
Newron Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Newron Stock often depends not only on the future outlook of the current and potential Newron Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Newron Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 17.8 M | |
| Cash And Short Term Investments | 34.6 M |
Newron Pharmaceuticals Technical Analysis
Newron Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Newron Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Newron Pharmaceuticals SpA. In general, you should focus on analyzing Newron Stock price patterns and their correlations with different microeconomic environments and drivers.
Newron Pharmaceuticals Predictive Forecast Models
Newron Pharmaceuticals' time-series forecasting models is one of many Newron Pharmaceuticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Newron Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Newron Pharmaceuticals
Checking the ongoing alerts about Newron Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Newron Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Newron Pharmaceuticals generated a negative expected return over the last 90 days | |
| Newron Pharmaceuticals has high historical volatility and very poor performance | |
| Newron Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 5.76 M. Net Loss for the year was (14.9 M) with profit before overhead, payroll, taxes, and interest of 5.76 M. | |
| Newron Pharmaceuticals SpA has accumulated about 58.99 M in cash with (11.45 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.31. |
Additional Tools for Newron Stock Analysis
When running Newron Pharmaceuticals' price analysis, check to measure Newron Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Newron Pharmaceuticals is operating at the current time. Most of Newron Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Newron Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Newron Pharmaceuticals' price. Additionally, you may evaluate how the addition of Newron Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.